Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 1
2021 5
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

17 results
Results by year
Filters applied: . Clear all
Page 1
Nanodrugs Targeting T Cells in Tumor Therapy.
Haist M, Mailänder V, Bros M. Haist M, et al. Front Immunol. 2022 May 25;13:912594. doi: 10.3389/fimmu.2022.912594. eCollection 2022. Front Immunol. 2022. PMID: 35693776 Free PMC article. Review.
eHealth Literacy in German Skin Cancer Patients.
Stege H, Schneider S, Forschner A, Eigentler T, Nashan D, Huening S, Meiss F, Lehr S, Kaatz M, Kuchen R, Kaehler KC, Haist M, Huebner J, Loquai C. Stege H, et al. Among authors: haist m. Int J Environ Res Public Health. 2022 Jul 8;19(14):8365. doi: 10.3390/ijerph19148365. Int J Environ Res Public Health. 2022. PMID: 35886215 Free PMC article.
Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study.
Stege H, Haist M, Schultheis M, Fleischer MI, Mohr P, Meier F, Schadendorf D, Ugurel S, Livingstone E, Zimmer L, Herbst R, Pföhler C, Kähler K, Weichenthal M, Terheyden P, Nashan D, Debus D, Kaatz M, Ziller F, Haferkamp S, Forschner A, Leiter U, Kreuter A, Ulrich J, Kleemann J, Bradfisch F, Grabbe S, Loquai C. Stege H, et al. Among authors: haist m. Cancers (Basel). 2021 May 12;13(10):2312. doi: 10.3390/cancers13102312. Cancers (Basel). 2021. PMID: 34065877 Free PMC article.
Systemically Administered TLR7/8 Agonist and Antigen-Conjugated Nanogels Govern Immune Responses against Tumors.
Stickdorn J, Stein L, Arnold-Schild D, Hahlbrock J, Medina-Montano C, Bartneck J, Ziß T, Montermann E, Kappel C, Hobernik D, Haist M, Yurugi H, Raabe M, Best A, Rajalingam K, Radsak MP, David SA, Koynov K, Bros M, Grabbe S, Schild H, Nuhn L. Stickdorn J, et al. Among authors: haist m. ACS Nano. 2022 Mar 22;16(3):4426-4443. doi: 10.1021/acsnano.1c10709. Epub 2022 Feb 1. ACS Nano. 2022. PMID: 35103463 Free PMC article.
Anticoagulation with Factor Xa Inhibitors Is Associated with Improved Overall Response and Progression-Free Survival in Patients with Metastatic Malignant Melanoma Receiving Immune Checkpoint Inhibitors-A Retrospective, Real-World Cohort Study.
Haist M, Stege H, Pemler S, Heinz J, Fleischer MI, Graf C, Ruf W, Loquai C, Grabbe S. Haist M, et al. Cancers (Basel). 2021 Oct 12;13(20):5103. doi: 10.3390/cancers13205103. Cancers (Basel). 2021. PMID: 34680252 Free PMC article.
Impaired regulatory T cell-dendritic cell interactions contribute to autoimmunity in leukocyte adhesion deficiency type-1.
Klaus T, Wilson AS, Vicari E, Hadaschik E, Klein M, Helbich SS, Kamenjarin N, Hodapp K, Schunke J, Haist M, Butsch F, Probst HC, Enk AH, Mahnke K, Waisman A, Bednarczyk M, Bros M, Bopp T, Grabbe S. Klaus T, et al. Among authors: haist m. JCI Insight. 2022 Nov 8:e162580. doi: 10.1172/jci.insight.162580. Online ahead of print. JCI Insight. 2022. PMID: 36346673 Free article.
17 results